Loading...
Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies
Immune checkpoint inhibitors (ICI) including programmed death 1 (PD-1) inhibitors, such as nivolumab and pembrolizumab, or programmed death ligand 1 (PD-L1) inhibitors, such as atezolizumab and durvalumab, have recently emerged in advanced stage lung cancer as new standards of care. They are now ind...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354161/ https://ncbi.nlm.nih.gov/pubmed/32676356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.23 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|